Slide

Featured

Webinar: Functional Characterization of iPSC-Derived Neurons and Glial Cells Using MEA and Calcium Flux Technologies

Register for our new webinar to learn how iPSC-derived neurons and glia are used in MEA and calcium flux assays to model neurological disease and evaluate compound activity.

Register Now

Quick-Tissue™
Platform

Generating human cells from iPSCs.

Proprietary transcriptional database identifies optimal differentiation paths
Directed protocols rapidly convert iPSCs into defined human cell types
Reproducible generation of functional, human-relevant cells
Scalable platform for drug discovery, disease modeling, and cell therapy

Quick-Tissue platform diagram showing iPSC differentiation into cardiomyocytes, natural killer cells, hepatocytes, glial cells, and neurons

Better decisions. Faster therapies.

We transform drug development decisions and accelerate new therapies through iPSC technology.

View All Services

Services

Human biology that translates.
Data you can act on.

Custom iPSC Differentiation → Your cell line. Our protocols. Decision-ready in weeks. New Cell Type Development → When no cells exist for your question, we build it. Disease Modeling → Patient biology, before patient trials. Custom Assay Services → Cells are the substrate. Data is the deliverable.

Our
Products

Generate translatable data faster with ready-to-use human iPSC-derived cell types and differentiation kits, available off-the-shelf for drug discovery, disease modeling, and downstream assays.

Neural Precursor Cells

Quick-Muscle™

Skeletal Muscle

Custom

Can’t Find Your Cells?

The Ricoh
Biosciences
Difference

Generate physiologically relevant human cell types in as little as 1 week using our proprietary iPSC differentiation platform. Standardized, scalable workflows give any lab access to diverse, functional cell models built for drug discovery and translational research.

Fast

Generate differentiated cell and tissue types from human iPSCs and ESCs in as little as 1 week — via ready-to-use kits or full-service production.

Flexible

Our transcription factor-based workflows differentiate virtually any iPSC or ESC line, expanding your options across cell type, disease state, and genetic background.

Functional

Our differentiation technology produces functional, physiologically relevant cell-based models that more accurately recapitulate human biology.

Scalable

Scale to virtually unlimited quantities of batch-consistent human cells, supporting high-throughput and high-content screening at any stage of your pipeline.